Novartis Recalls over 5 Million Bottles of Potentially Contaminated Drugs
Novartis has recalled over 5 million bottles of antihypersentives, statins and other drugs following concerns that the drugs may have been contaminated by a chemical used in the company’s packaging process.
About the Novartis Recall
According to Medscape, the U.S. Food and Drug Administration has confirmed a class-2 recall for a total of 127 drug lots distributed by Novartis to physicians as free samples.
Novartis is currently unsure how many samples may have reached customers, but has sent letters to physicians who received the samples and is working with them to return the recalled products.
The company has also confirmed that they will no longer be using an ink component produced by a third party to mark sample sleeves and, over time, migrated through the sleeve and bottle and into the drugs.
Products Affected by the Medicine Recall
Drugs affected by the recall include:
- Exforge (amlodipine and valsartan)
- Exforge HCT (w/ hydrochlorothiazide)
- Diovan (valsartan)
- Tekturna (aliskiren)
- Tekturna HCT (w/ hydrochlorothiazide)
- Lexcol XL (fluvastatin)
- Stalevo (carbidopa, levodopa, and entacopone)
Contact an Experienced Drug Recall Attorney
Thomas J. Henry are leaders in the area of drug and product liability litigation. Our Defective Drug and Products Division have extensive knowledge and resources in order to represent our clients efficiently and aggressively. The Defective Drug and Products Division represent a multitude of people who are battling against manufacturers of medical devices and/or defective pharmaceuticals.
If you or a loved one have been injured by or have developed serious side-effects from the use of recalled medications or pharmaceuticals, contact Thomas J. Henry immediately. We represent clients/victims all over the country. We are available 24/7, nights and weekends.